Putative effect of melatonin on cardiomyocyte senescence in mice with type 1 diabetes mellitus.

In general, one can hypothesize that modulation of different effectors associated with aging is beneficial to alleviate cardiac injuries under hypergylcemic condition. Melatonin can exert its therapeutic effects, in part, through anti-aging capacity.